Moonwalk Biosciences uses advanced AI to predict epigenetic targets to treat aging-related diseases.
Moonwalk Biosciences, co-founded by CRISPR pioneer Feng Zhang and former Illumina CTO Alex Aravanis, has secured $57 million in funding to advance gene therapy with its epigenetic editing technology.
The gene therapy market, set to surge from $7.18 billion in 2024 to $24.67 billion by 2029, continues to innovate with Moonwalk's non-invasive epigenetic editing. This method, targeting epigenetic modifications over DNA alteration, provides safer, more effective treatments for chronic and aging-related diseases.
“Epigenetics is the software of the genome. While changes to the genome are irreversible, edits to the epigenome can be reprogrammed in different ways. Epigenetic changes determine whether genes are turned on or off, and can potentially reverse disease, broadening the therapeutic landscape to find potential cures previously thought impossible,” said Alex Aravanis, M.D., Ph.D., CEO and Co-Founder, Moonwalk Biosciences.
The next steps include clinical trials to validate the safety and efficacy of its epigenetic editing technique. As this technology advances, it could challenge the industry's belief that traditional gene editing, such as CRISPR-Cas9, is the only path forward for gene therapy.
Moonwalk's approach, utilizing AI for predicting epigenetic targets, leverages the body's natural regulation system, offering a nuanced approach to gene control. This resonates with the trend in biotechnology towards precision and personalization, moving away from one-size-fits-all solutions.
<script type="application/ld+json">
{
"@context": "https://schema.org",
"@type": "Article",
"mainEntityOfPage": {
"@type": "WebPage",
"@id": "https://www.themoney.game/stories/biotech-startup-secures-57m-for-non-invasive-gene-editing-technology"
},
"headline": "Biotech Startup Secures $57M for Non-Invasive Gene Editing Technology",
"description": "Moonwalk Biosciences uses advanced AI to predict epigenetic targets to treat aging-related diseases.",
"image": "",
"author": {
"@type": "Organization",
"name": "The Money Game",
"url": "https://www.themoney.game"
},
"publisher": {
"@type": "Organization",
"name": "",
"logo": {
"@type": "ImageObject",
"url": ""
}
},
"datePublished": "2024-01-11"
}
</script>
Actions
Pages
Subscribe for newsletter
Stories
Why it matters:
“Tether Investments’ financing of this significant crude oil transaction underscores our commitment to reshaping the trade finance landscape. With USD₮, we’re bringing efficiency and speed to markets that have historically relied on slower, more costly payment structures,” stated Paolo Ardoino, Tether CEO.
Story
“We’re proud to be at the forefront of bringing responsible AI solutions to U.S. classified environments, enhancing analytical capabilities and operational efficiencies in vital government operations,” stated Kate Earle, Anthropic’s head of sales.
Story
Story
Innovators
Scroll
Open
Close